Vasalgel in the media spotlight

Linda Brent, PhD

Executive Director, Parsemus Foundation

Our recent news update prompted a great deal of media attention, ranging from national and international news outlets to local newspapers. Vasalgel was even mentioned on the Stephen Colbert Report. With Vasalgel’s baboon studies moving along successfully, and the first small human trial expected in 2015, the advent of a new male contraception option appears to be on the horizon. Some reporters expressed concern that men (and even women) may not accept this new form of birth control since it could radically change the status quo of reproductive control. Elaine Lissner, Director of Parsemus Foundation, and Gareth Cales, one of Vasalgel’s supporters, were interviewed by Alyona Minkovski of HuffPost Live on September 18, 2014 about this topic and helped to dispel any reservations. With over 19,000 men signed up to receive notification of clinical trials, it seems clear that men all over the world are seeking reversible, non-hormonal contraceptive options.

Selection of media coverage in September, 2014:

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today